The Board of Directors of Diasorin S.p.A. (FTSE MIB: DIA), examined and approved the Group’s Consolidated Financial Statements at June 30, 2025.

Siemens Healthineers AG today announces its results for the third quarter of fiscal year 2025 ended June 30, 2025.

Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2025.

Revvity, Inc. (NYSE: RVTY), today reported financial results for the second quarter ended June 29, 2025.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the second quarter ended June 30, 2025 and raised full-year guidance.

Roche (SIX: RO, ROG; OTCQX: RHHBY) expects an increase in Group sales in the mid single digit range (CER). Core earnings per share are targeted to develop in the high single digit range (CER). Roche expects to further increase its dividend in Swiss francs.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 28, 2025.

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended June 27, 2025.

Shares of Oxford Nanopore Technologies jumped 16 percent on Monday after the company reported strong preliminary revenues for the first half of 2025.

In a letter to customers on Wednesday, Bio-Rad Laboratories announced that it has decided against implementing a tariff surcharge that the company on May 21 said it was considering for at least some of its products. The surcharge came following the firm's disclosure of approximately $40 million in tariff-related revenue headwinds for 2025.